Schroder Investment Management Group
INSP icon

Schroder Investment Management Group’s Inspire Medical Systems INSP Stock Holding History

Schroder Investment Management Group’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,692
Closed -$3.72M – 1220
2025
Q2 		$3.72M Sell
28,692
-1,870
-6% -$271K ﹤0.01% 823
2025
Q1 		$4.87M Buy
+30,562
New +$5.53M ﹤0.01% 760

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Schroder Investment Management Group's INSP Position: Q3 2025 in Review

Schroder Investment Management Group sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 28,692 shares — an estimated $3.72M sold.

Schroder Investment Management Group first reported a position in INSP in Q1 2025 and held it in 2 quarters. The position peaked at $4.87M in Q1 2025. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Schroder Investment Management Group reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 28,692 Inspire Medical Systems shares in Q3 2025, an estimated $3.72M.
  • Schroder Investment Management Group first reported a position in Inspire Medical Systems in Q1 2025 and held it in 2 quarters.
  • Schroder Investment Management Group's Inspire Medical Systems position peaked at $4.87M in Q1 2025.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Schroder Investment Management Group's 13F filing for Q3 2025, filed 13 Nov 2025.